Treace Medical Concepts, Inc. (TMCI)
NASDAQ: TMCI · Real-Time Price · USD
2.275
-0.045 (-1.94%)
Feb 2, 2026, 2:50 PM EST - Market open

Treace Medical Concepts Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
1454637861,276991-
Market Cap Growth
-72.53%-41.06%-38.37%28.74%--
Enterprise Value
1614517351,259911-
Last Close Price
2.327.4412.7522.9918.64-
PS Ratio
0.672.214.209.0010.50-
PB Ratio
1.664.115.7021.0810.65-
P/TBV Ratio
2.145.046.7721.0810.65-
EV/Sales Ratio
0.732.153.938.889.65-
Debt / Equity Ratio
0.790.620.511.130.3240.24
Debt / EBITDA Ratio
-----15.12
Asset Turnover
1.070.890.910.951.031.60
Inventory Turnover
1.041.201.451.711.841.86
Quick Ratio
2.223.353.613.676.832.81
Current Ratio
3.374.624.414.417.583.53
Return on Equity (ROE)
-51.63%-44.45%-49.91%-55.75%-43.80%-186.34%
Return on Assets (ROA)
-14.77%-14.83%-15.64%-14.53%-11.30%1.49%
Return on Capital Employed (ROCE)
-31.10%-30.50%-24.90%-27.10%-13.50%2.80%
Earnings Yield
-33.90%-12.03%-6.30%-3.36%-2.07%-
FCF Yield
-17.82%-10.52%-5.85%-3.56%-2.01%-
Buyback Yield / Dilution
-1.51%-2.07%-10.09%-14.17%-30.61%-0.43%
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q